230 related articles for article (PubMed ID: 36927966)
1. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.
Kasugai K; Ogasawara N
Intern Med; 2024 Jan; 63(1):1-10. PubMed ID: 36927966
[TBL] [Abstract][Full Text] [Related]
2. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
[TBL] [Abstract][Full Text] [Related]
3. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
Ota K; Takeuchi T; Higuchi K; Sasaki S; Mori Y; Tanaka H; Hakoda A; Sugawara N; Iwatsubo T; Nishikawa H
Digestion; 2024; 105(1):5-10. PubMed ID: 37591209
[TBL] [Abstract][Full Text] [Related]
4. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.
Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K
BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic anti-reflux mucosectomy (ARMS) and endoscopic anti-reflux ablation (ARMA) as a potential treatment for gastroesophageal reflux - preliminary report.
Klimczak T; Strzelczyk J
Pol Przegl Chir; 2023 Oct; 96(0):1-5. PubMed ID: 38348994
[TBL] [Abstract][Full Text] [Related]
7. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
8. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
[TBL] [Abstract][Full Text] [Related]
10. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
11. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
Kalapala R; Singla N; Reddy DN
Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
[TBL] [Abstract][Full Text] [Related]
14. Anti-reflux mucosectomy (ARMS) for refractory gastroesophageal reflux disease.
Zhu X; Shen J
Eur J Med Res; 2024 Mar; 29(1):185. PubMed ID: 38500203
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of esophageal and gastric pH measurements in patients with gastro-esophageal reflux disease (GERD).
DiMarino AJ; Cohen S
Curr Med Res Opin; 2005 Jan; 21(1):27-36. PubMed ID: 15881473
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative impact of anti-reflux mucosal intervention on gastroesophageal reflux disease.
Chou CK; Chen CC; Chen CC; Wu JF; Liao WC; Chiu HM; Wang HP; Wu MS; Tseng PH
Surg Endosc; 2023 Feb; 37(2):1060-1069. PubMed ID: 36109362
[TBL] [Abstract][Full Text] [Related]
17. Management of gastroesophageal reflux disease: medications, surgery, or endoscopic therapy? (Current status and trends).
Zhi XT; Kavic SM; Park AE
J Long Term Eff Med Implants; 2005; 15(4):375-88. PubMed ID: 16022648
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid.
Sharma P; Yadlapati R
Ann N Y Acad Sci; 2021 Feb; 1486(1):3-14. PubMed ID: 33015827
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.
Shibli F; Kitayama Y; Fass R
Curr Gastroenterol Rep; 2020 Mar; 22(4):16. PubMed ID: 32185589
[TBL] [Abstract][Full Text] [Related]
20. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
